Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tayfur Toptas

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 7, 2022
Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphomaCeren Uzunoglu Guren, Tayfur Toptas, Ozgur Mehtap, et al.
Journal of Clinical Medicine|November 13, 2025
The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic LeukemiaOzlem Candan, Imren Tatli, Abdullah Bakisli, et al.
Transplantation Proceedings|January 11, 2024
Efficacy and Reliability of T-Cell-Depleted Haploidentical Stem Cell Transplantation in Hematologic Disorders: A Retrospective StudyBurak Deveci, George Kublashvili, Ayse Tuba Oztekin, et al.
Medicine|March 6, 2026
HIV-associated lymphoproliferative disorders: Single-center experienceDerya Demirtas, Tayfur Toptas, Asu Fergun Yilmaz, et al.
Bone Marrow Transplantation|April 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemiasAbdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal, et al.
Leukemia Research|April 25, 2016
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter studyOzan Salim, Tayfur Toptas, Esin Avsar, et al.
Frontiers in Medicine|June 1, 2026
Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort studyOzlem Candan, Narmin Naghizada, Tekin Tuncel, et al.
Journal of Clinical Medicine|October 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and MicafunginUnal Atas, Utku Iltar, Orhan Kemal Yucel, et al.
Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.
Annals of Hematology|June 9, 2020
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceHuseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 7, 2022
Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphomaCeren Uzunoglu Guren, Tayfur Toptas, Ozgur Mehtap, et al.
Journal of Clinical Medicine|November 13, 2025
The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic LeukemiaOzlem Candan, Imren Tatli, Abdullah Bakisli, et al.
Transplantation Proceedings|January 11, 2024
Efficacy and Reliability of T-Cell-Depleted Haploidentical Stem Cell Transplantation in Hematologic Disorders: A Retrospective StudyBurak Deveci, George Kublashvili, Ayse Tuba Oztekin, et al.
Medicine|March 6, 2026
HIV-associated lymphoproliferative disorders: Single-center experienceDerya Demirtas, Tayfur Toptas, Asu Fergun Yilmaz, et al.
Bone Marrow Transplantation|April 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemiasAbdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal, et al.
Leukemia Research|April 25, 2016
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter studyOzan Salim, Tayfur Toptas, Esin Avsar, et al.
Frontiers in Medicine|June 1, 2026
Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort studyOzlem Candan, Narmin Naghizada, Tekin Tuncel, et al.
Journal of Clinical Medicine|October 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and MicafunginUnal Atas, Utku Iltar, Orhan Kemal Yucel, et al.
Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.
Annals of Hematology|June 9, 2020
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceHuseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, et al.
Pageof 5